Losapot-H

Losapot-H may be available in the countries listed below.

Ingredient matches for Losapot-H

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Losapot-H in the following countries:

• India

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losapot-H in the following countries:

• India

International Drug Name Search

B-12 Dots

Pronunciation: sigh-an-oh-koe-BAL-uh-min
Generic Name: Cyanocobalamin (B12)
Brand Name: B-12 Dots

B-12 Dots is used for:

Treating or preventing low blood levels of vitamin B₁₂. It may also be used for other conditions as determined by your doctor.

B-12 Dots is a form of vitamin B₁₂. It works by replacing vitamin B₁₂ in the body.

Do NOT use B-12 Dots if:

• you are allergic to any ingredient in B-12 Dots, including cobalt

Contact your doctor or health care provider right away if any of these apply to you.

Before using B-12 Dots:

Some medical conditions may interact with B-12 Dots. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have an infection, Leber disease (weakened eye nerve), a buildup of waste in the blood (uremia), any kind of anemia, or low blood levels of iron or folic acid


• if you are a vegetarian


• if you drink alcohol on a regular basis

Some MEDICINES MAY INTERACT with B-12 Dots. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Chloramphenicol or other medicine that may decrease your bone marrow because effectiveness of B-12 Dots may be decreased; ask your doctor if you are unsure if any of your medicines may decrease your bone marrow


• Colchicine or para-aminosalicylic acid because the effectiveness of B-12 Dots may be decreased

This may not be a complete list of all interactions that may occur. Ask your health care provider if B-12 Dots may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use B-12 Dots:

Use B-12 Dots as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• B-12 Dots may be taken with or without food.


• Place B-12 Dots beneath your tongue and allow the tablet to dissolve.


• If you miss a dose of B-12 Dots, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use B-12 Dots.

Important safety information:

• Heavy alcohol intake for more than 2 weeks may decrease the effectiveness of B-12 Dots. Check with your doctor if you drink alcohol on a regular basis.


• You may need to have blood tests every 3 to 6 months to monitor your progress.


• Certain medicines, including antibiotics, methotrexate, or pyrimethamine, may interfere with lab tests for vitamin B₁₂ and folic acid. Be sure your doctor and lab personnel know all the medicines that you are taking.


• Do not take large doses of vitamins (megadoses or megavitamin therapy) while taking B-12 Dots unless directed by your doctor.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking B-12 Dots, discuss with your doctor the benefits and risks of using B-12 Dots during pregnancy. B-12 Dots is excreted in breast milk. If you are or will be breast-feeding while you are using B-12 Dots, check with your doctor or pharmacist to discuss the risks to your baby.

Possible side effects of B-12 Dots:

All medicines may cause side effects, but many people have no, or minor, side effects. When used in small doses, no COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: B-12 Dots side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of B-12 Dots:

Store B-12 Dots at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Store upright. Do not freeze. Do not store in the bathroom. Keep B-12 Dots out of the reach of children and away from pets.

General information:

• If you have any questions about B-12 Dots, please talk with your doctor, pharmacist, or other health care provider.


• B-12 Dots is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about B-12 Dots. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More B-12 Dots resources

• B-12 Dots Side Effects (in more detail)
• B-12 Dots Use in Pregnancy & Breastfeeding
• B-12 Dots Drug Interactions
• B-12 Dots Support Group
• 0 Reviews for B-12 Dots - Add your own review/rating

• Cyanocobalamin Prescribing Information (FDA)


• Calomist Prescribing Information (FDA)


• Calomist Consumer Overview


• Nascobal Prescribing Information (FDA)


• Nascobal Monograph (AHFS DI)


• Vitamin b12


• vitamin b12 Nasal, Oral, Parenteral Advanced Consumer (Micromedex) - Includes Dosage Information

Compare B-12 Dots with other medications

• B12 Nutritional Deficiency
• Pernicious Anemia
• Schilling Test
• Vitamin B12 Deficiency

Atorvastatina Genfar

Atorvastatina Genfar may be available in the countries listed below.

Ingredient matches for Atorvastatina Genfar

Atorvastatin

Atorvastatin is reported as an ingredient of Atorvastatina Genfar in the following countries:

• Chile


• Colombia


• Ecuador

International Drug Name Search

Zoleta

Zoleta may be available in the countries listed below.

Ingredient matches for Zoleta

Imatinib

Imatinib mesilate (a derivative of Imatinib) is reported as an ingredient of Zoleta in the following countries:

• India

International Drug Name Search

Rescriptor

Rescriptor is a brand name of delavirdine, approved by the FDA in the following formulation(s):

RESCRIPTOR (delavirdine mesylate - tablet; oral)

• 
  Manufacturer: VIIV HLTHCARE
  
  Approval date: April 4, 1997
  
  Strength(s): 100MG
  


• 
  Manufacturer: VIIV HLTHCARE
  
  Approval date: July 14, 1999
  
  Strength(s): 200MG ^[RLD]

Has a generic version of Rescriptor been approved?

No. There is currently no therapeutically equivalent version of Rescriptor available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rescriptor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Diaromatic substituted compounds as anti-HIV-1 agents
  Patent 5,563,142
  Issued: October 8, 1996
  Inventor(s): Palmer; John R. & Romero; Donna L. & Aristoff; Paul A. & Thomas; Richard C. & Smith; Herman W.
  Assignee(s): The Upjohn Company
  The present invention includes diaromatic substituted heterocyclic compounds (III) ##STR1## which are useful in treating individuals infected with the HIV virus.
  
  Patent expiration dates:
  
  
  • October 8, 2013
    
  
  



• 
  Delavirdine high strength tablet formulation
  Patent 6,177,101
  Issued: January 23, 2001
  Inventor(s): Martino; Alice C. & Bates; Ashley H. & Morozowich; Walter & Lee; E. John
  Assignee(s): Pharmacia & Upjohn Company
  Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the group consisting of a binder in an amount of from about 2 to about 25% and a superdisintegrant in an amount from about 6 to about 40% where the rapidly precipitating drug, "binder" and superdisintegrant are mixed and compressed into a tablet without heating, solvent or grinding.
  
  Patent expiration dates:
  
  
  • June 7, 2019
    
  
  

See also...

• Rescriptor Consumer Information (Wolters Kluwer)
• Rescriptor Consumer Information (Cerner Multum)
• Rescriptor Advanced Consumer Information (Micromedex)
• Rescriptor AHFS DI Monographs (ASHP)
• Delavirdine Consumer Information (Wolters Kluwer)
• Delavirdine Consumer Information (Cerner Multum)
• Delavirdine Advanced Consumer Information (Micromedex)
• Delavirdine Mesylate AHFS DI Monographs (ASHP)

Cefpodoxima Sandoz

Cefpodoxima Sandoz may be available in the countries listed below.

Ingredient matches for Cefpodoxima Sandoz

Cefpodoxime

Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Cefpodoxima Sandoz in the following countries:

• Spain

International Drug Name Search

Nimesulid Domesco

Nimesulid Domesco may be available in the countries listed below.

Ingredient matches for Nimesulid Domesco

Nimesulide

Nimesulide is reported as an ingredient of Nimesulid Domesco in the following countries:

• Vietnam

International Drug Name Search

Dedralen

Dedralen may be available in the countries listed below.

Ingredient matches for Dedralen

Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Dedralen in the following countries:

• Italy

International Drug Name Search

Carbolitium

Carbolitium may be available in the countries listed below.

Ingredient matches for Carbolitium

Lithium

Lithium carbonate (a derivative of Lithium) is reported as an ingredient of Carbolitium in the following countries:

• Brazil

International Drug Name Search

Glucosamil

Glucosamil may be available in the countries listed below.

Ingredient matches for Glucosamil

Glucosamine

Glucosamine hydrochloride (a derivative of Glucosamine) is reported as an ingredient of Glucosamil in the following countries:

• Greece

Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Glucosamil in the following countries:

• Greece

International Drug Name Search

Rofact

Rofact may be available in the countries listed below.

Ingredient matches for Rofact

Rifampicin

Rifampicin is reported as an ingredient of Rofact in the following countries:

• Canada

International Drug Name Search